Juan Luis Peréz-Salas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Juan Luis Peréz-Salas has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- José Alberto Gallegos-Infante
Tecnológico Nacional de México/Instituto Tecnológico de Durango, Laboratorio Nacional Conacyt-LaNAEPBi, Blvd. Felipe Pescador 1830 Ote., C.P. 34080 Durango, Dgo. México
2 shared publications - Martha Rocío Moreno-Jiménez
Departamento de Ingenierías Química y Bioquímica, Tecnológico Nacional de México, Instituto Tecnológico de Durango, Blvd. Felipe Pescador 1830 Ote., Durango 34080, Mexico
2 shared publications - Rubén Francisco González-Laredo
Instituto Tecnológico de Durango
2 shared publications - Luis Medina-Torres
Universidad Nacional Autónoma de México
1 shared publication - Luis Medina-Torres
Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México 04510, México
1 shared publication - María Josefa Bernad-Bernad
Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México 04510, México
1 shared publication
Latest Publications
- Open Access
- 3 July 2025
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 93 (3) , 28
Development and Characterization of Bigels for the Topical Delivery of Curcumin
The topical application of curcumin can act directly on the tissue, but there are problems related to solubility and permeation. Bigels combine hydrogels and organogels to enhance the release and transport of bioactives through the skin. The aim of this study was to develop bigels for the topical delivery of curcumin. Employing a rheology test, it was found that all bigels showed a solid-like behavior structure (G′ > G″) with stiffness increasing with higher organogel content. The principle of time–temperature superposition (TTS) was used to generate master curves. Microscopy revealed a morphological structure that depended on the organogel/hydrogel ratio. The bigels exhibited a pH compatible with that of human skin, and the curcumin content met the standards for uniform dosage. Thermal characterization showed the presence of three peaks in coconut oil bigels and two peaks in castor oil bigels. Bigels with a 45% castor oil organogel/55% hydrogel ratio exhibited a longer controlled release of curcumin, while bigels with coconut oil showed a faster release. The release data were fitted to mathematical models indicating non-Fickian release. The permeability of curcumin through Strat-M membranes was investigated, and greater permeation was observed with increasing organogel content. The developed bigels could be a promising option for the topical delivery of curcumin.
- 3 July 2025
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 93 (3) , 28
Open AccessDevelopment and Characterization of Bigels for the Topical Delivery of Curcumin
The topical application of curcumin can act directly on the tissue, but there are problems related to solubility and permeation. Bigels combine hydrogels and organogels to enhance the release and transport of bioactives through the skin. The aim of this study was to develop bigels for the topical delivery of curcumin. Employing a rheology test, it was found that all bigels showed a solid-like behavior structure (G′ > G″) with stiffness increasing with higher organogel content. The principle of time–temperature superposition (TTS) was used to generate master curves. Microscopy revealed a morphological structure that depended on the organogel/hydrogel ratio. The bigels exhibited a pH compatible with that of human skin, and the curcumin content met the standards for uniform dosage. Thermal characterization showed the presence of three peaks in coconut oil bigels and two peaks in castor oil bigels. Bigels with a 45% castor oil organogel/55% hydrogel ratio exhibited a longer controlled release of curcumin, while bigels with coconut oil showed a faster release. The release data were fitted to mathematical models indicating non-Fickian release. The permeability of curcumin through Strat-M membranes was investigated, and greater permeation was observed with increasing organogel content. The developed bigels could be a promising option for the topical delivery of curcumin.
- Open Access
- 17 April 2023
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 91 (2) , 20
In Vitro and Ex Vivo Models for Screening Topical Anti-Inflammatory Drugs
Skin inflammation occurs as an immune response to various stimuli such as ultraviolet light, irritants, or any type of skin barrier injury. Finding safe and effective drugs to combat skin inflammation remains a research challenge. Ethical and legal considerations in animal testing encourage the development of in vitro and ex vivo models for the detection of skin inflammation. This report presents an updated review of non-animal study models available for screening drugs with anti-inflammatory potential. It includes a description of the basic methods used to inhibit protein denaturation and red blood cell membrane stability. Three in vitro inhibition assay methods for enzymes relevant to the skin inflammatory process are then described. The development of cell culture models is described: relatively simple and easy-to-produce two-dimensional (2D) skin cell cultures that allow assessment of response to a given stimulus, three-dimensional (3D) cell cultures that better mimic human skin physiology by more accurately replicating mechanical and chemical signals, and vascularized 3D skin models with dynamic perfusion and microfluidic devices known as skin on a chip. Finally, ex vivo skin models are presented that could more accurately represent human skin in terms of structure, cell signaling mechanisms, and absorption effects. Although the current development of models without the use of animals is promising, improvements and refinements are needed to make the models more suitable as screening platforms for topical anti-inflammatory drugs.
- 17 April 2023
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 91 (2) , 20
Open AccessIn Vitro and Ex Vivo Models for Screening Topical Anti-Inflammatory Drugs
Skin inflammation occurs as an immune response to various stimuli such as ultraviolet light, irritants, or any type of skin barrier injury. Finding safe and effective drugs to combat skin inflammation remains a research challenge. Ethical and legal considerations in animal testing encourage the development of in vitro and ex vivo models for the detection of skin inflammation. This report presents an updated review of non-animal study models available for screening drugs with anti-inflammatory potential. It includes a description of the basic methods used to inhibit protein denaturation and red blood cell membrane stability. Three in vitro inhibition assay methods for enzymes relevant to the skin inflammatory process are then described. The development of cell culture models is described: relatively simple and easy-to-produce two-dimensional (2D) skin cell cultures that allow assessment of response to a given stimulus, three-dimensional (3D) cell cultures that better mimic human skin physiology by more accurately replicating mechanical and chemical signals, and vascularized 3D skin models with dynamic perfusion and microfluidic devices known as skin on a chip. Finally, ex vivo skin models are presented that could more accurately represent human skin in terms of structure, cell signaling mechanisms, and absorption effects. Although the current development of models without the use of animals is promising, improvements and refinements are needed to make the models more suitable as screening platforms for topical anti-inflammatory drugs.